We are pleased to announce our top profile speakers who will share real-case experiences with us ;
· Miyang Kim, Associate Director SROL, Merck Korea
Ms. Kim is in charge of managing site relationship for Korean trials at Merck Korea. As a global leading company in new drug development, Merck has been actively working on Risk Based Monitoring plan which is becoming essential in Europe and US trials. She will be talking about her experiences on efficient site monitoring and what would be the benefits and pitfalls of Risk Base Monitoring.
·Shunsuke Abe, Head of Scientific & Clinical Procurement, BMS Japan
Mr. Abe is a well-known speaker as he has been actively participating conferences and sharing opinions. He is managing vendor relationships as well as clinical operations of Japanese trials at BMS. He will be speaking about Japanese regulations which are difficult to understand for non-Japanese professionals who are planning to conduct clinical trials in Japan sooner of later and have active Q&A time with attendee on this topic.
· Yan Wu, VP, Head of Clinical Operation, Hutchison Medipharma China
: Dr.Wu is a Vice President of Hutchison Medipharma which is one of the major pharmaceutical companies in China and has been in the industry for more than 20 years. Yan has various experience from multinational trial companies to consulting agencies, he will be sharing case studies on how to work with CROs and the best case studies. As China joined the ICH, it is becoming easier for international companies to conduct clinical trials in China – Yan will be explaining what would be the main changes and how to find right CROs for their study in China.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948